192 related articles for article (PubMed ID: 23051772)
1. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
[TBL] [Abstract][Full Text] [Related]
2. Metabolic profiling detects biomarkers of protein degradation in COPD patients.
Ubhi BK; Riley JH; Shaw PA; Lomas DA; Tal-Singer R; MacNee W; Griffin JL; Connor SC
Eur Respir J; 2012 Aug; 40(2):345-55. PubMed ID: 22183483
[TBL] [Abstract][Full Text] [Related]
3. Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk.
Langholm LL; Rønnow SR; Sand JMB; Leeming DJ; Tal-Singer R; Miller BE; Vestbo J; Karsdal MA; Manon-Jensen T
Int J Chron Obstruct Pulmon Dis; 2020; 15():543-552. PubMed ID: 32210548
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
Pratte KA; Curtis JL; Kechris K; Couper D; Cho MH; Silverman EK; DeMeo DL; Sciurba FC; Zhang Y; Ortega VE; O'Neal WK; Gillenwater LA; Lynch DA; Hoffman EA; Newell JD; Comellas AP; Castaldi PJ; Miller BE; Pouwels SD; Hacken NHTT; Bischoff R; Klont F; Woodruff PG; Paine R; Barr RG; Hoidal J; Doerschuk CM; Charbonnier JP; Sung R; Locantore N; Yonchuk JG; Jacobson S; Tal-Singer R; Merrill D; Bowler RP
Respir Res; 2021 Apr; 22(1):127. PubMed ID: 33906653
[TBL] [Abstract][Full Text] [Related]
5. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
6. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.
Albert P; Agusti A; Edwards L; Tal-Singer R; Yates J; Bakke P; Celli BR; Coxson HO; Crim C; Lomas DA; Macnee W; Miller B; Rennard S; Silverman EK; Vestbo J; Wouters E; Calverley P
Thorax; 2012 Aug; 67(8):701-8. PubMed ID: 22696176
[TBL] [Abstract][Full Text] [Related]
8. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
[TBL] [Abstract][Full Text] [Related]
9. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D, vitamin D binding protein, lung function and structure in COPD.
Berg I; Hanson C; Sayles H; Romberger D; Nelson A; Meza J; Miller B; Wouters EF; Macnee W; Rutten EP; Romme EA; Vestbo J; Edwards L; Rennard S
Respir Med; 2013 Oct; 107(10):1578-88. PubMed ID: 23809536
[TBL] [Abstract][Full Text] [Related]
11. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE).
Vestbo J; Anderson W; Coxson HO; Crim C; Dawber F; Edwards L; Hagan G; Knobil K; Lomas DA; MacNee W; Silverman EK; Tal-Singer R;
Eur Respir J; 2008 Apr; 31(4):869-73. PubMed ID: 18216052
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics Reveals Dysregulated Sphingolipid and Amino Acid Metabolism Associated with Chronic Obstructive Pulmonary Disease.
Kim J; Suresh B; Lim MN; Hong SH; Kim KS; Song HE; Lee HY; Yoo HJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2022; 17():2343-2353. PubMed ID: 36172036
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of soluble Fas ligand in cachexic patients with COPD are higher than those in non-cachexic patients with COPD.
Takabatake N; Arao T; Sata M; Inoue S; Abe S; Shibata Y; Kubota I
Intern Med; 2005 Nov; 44(11):1137-43. PubMed ID: 16357450
[TBL] [Abstract][Full Text] [Related]
15. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
16. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
17. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD.
Rabinovich RA; Miller BE; Wrobel K; Ranjit K; Williams MC; Drost E; Edwards LD; Lomas DA; Rennard SI; Agustí A; Tal-Singer R; Vestbo J; Wouters EF; John M; van Beek EJ; Murchison JT; Bolton CE; MacNee W; Huang JT;
Eur Respir J; 2016 May; 47(5):1365-73. PubMed ID: 27009168
[TBL] [Abstract][Full Text] [Related]
18. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
Di Stefano A; Coccini T; Roda E; Signorini C; Balbi B; Brunetti G; Ceriana P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1691-1700. PubMed ID: 29872287
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.
Wan ES; Cho MH; Boutaoui N; Klanderman BJ; Sylvia JS; Ziniti JP; Won S; Lange C; Pillai SG; Anderson WH; Kong X; Lomas DA; Bakke PS; Gulsvik A; Regan EA; Murphy JR; Make BJ; Crapo JD; Wouters EF; Celli BR; Silverman EK; DeMeo DL; ; ; ;
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):304-10. PubMed ID: 21037115
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
